Evidence map›Paper›PMID 23521712›Full record

ArticleParasite immunology2013

A late IL-33 response after exposure to Schistosoma haematobium antigen is associated with an up-regulation of IL-13 in human eosinophils.

S Wilson, F M Jones, H K M Fofana, A Landouré, G Kimani, J K Mwatha, M Sacko, B J Vennervald, D W Dunne

Open access · hybridAbstract read
In one paragraph

Article in Parasite immunology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Interleukin-33 in health and disease.Nature reviews. Immunology · 2016
    Review
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 4 countries.

S WilsonDepartment of Pathology, University of Cambridge, Cambridge, UK. sw320@cam.ac.uk
F M Jones
H K M Fofana
A Landouré
G Kimani
J K Mwatha
M Sacko
B J Vennervald
D W Dunne
Institut National de Recherche en Santé Publique · MLUniversity of Cambridge · GBKenya Medical Research Institute · KEUniversity of Copenhagen · DK

Funding

Wellcome Trust 083931/Z/07/Z
6 · The paper itself

Abstract

IL-33, a proposed alarmin, stimulates innate immune cells and Th2 cells to produce IL-13 and is rapidly upregulated upon antigen exposure in murine helminth infection. The human IL-33 response to helminth antigen was analysed in Malians infected with Schistosoma haematobium by disrupting parasite integrity via chemotherapy. Plasma IL-33 was measured pretreatment, and 24 h and 9 weeks post-treatment. At 24 h post-treatment, IL-33 levels were low. Nine week post-treatment IL-33 levels were elevated and were associated with an increase in intracellular IL-13 in eosinophils. Up-regulation of intracellular IL-13 in eosinophils was also associated with eosinophil expression of ST2L, the IL-33 receptor. IL-33 may play an important downstream role in the human response to schistosome adult worm antigen exposure.

Indexed as

AdolescentAdultAnimalsAntigens, HelminthChildChild, PreschoolEosinophilsFemaleHumansInterleukin-13Interleukin-1 Receptor-Like 1 ProteinInterleukin-33Interleukin-5InterleukinsMalePraziquantelAntigens, HelminthIL1RL1 protein, humanIL33 protein, humanInterleukin-13Interleukin-1 Receptor-Like 1 ProteinInterleukin-33Interleukin-5InterleukinsPraziquantelReceptors, Cell SurfaceSchistosomicideseosinophilshelminthhumanIL-13IL-33schistosomiasisST2

Identifiers

PMID23521712
PMCPMC4463766
OpenAlexW2050344016

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.